AzTrials
AzTrials

Cerebral PalsyNCT06667388

Effect of Backward Walking Training vs Forward Walking Training to Improve Balance and Mobility in Children With CP

A study testing Group A and Grojup B in people with Cerebral Palsy, run by Superior University at 1 site in Pakistan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Children with cerebral palsy frequently experience balance issues and gait impairments; gait training is a crucial component of their rehabilitation because it greatly enhances the children's socialisation and quality of life. Read more about this study

Who is it for?
Ages 6 to 14 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Group A and Grojup B
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 sitePakistan
Study dates
1 Nov 2023to 15 Nov 2024
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Only CP patients will be included.
  • Patient will be included from Bahawalpur only.
  • Patient will be included having minimum age of 10 year.

Who cannot join

  • Other cities patient will not be included.
  • Patient less than 10 years age.
  • Patient suffering from other neurological conditions.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • sadiq abbasi hospital bwp Contact: jangi wala road BWP

    Chak Eighty-seven -Twelve Left

Other trials in Pakistan

About this study

Official title: Effect of Backward Walking Training Versus Forward Walking Training Program to Improve Balance and Mobility in Children With Cerebral Palsy

Children with cerebral palsy frequently experience balance issues and gait impairments; gait training is a crucial component of their rehabilitation because it greatly enhances the children's socialisation and quality of life.

Read the detailed description

Since there is no known cure for cerebral palsy, the focus of treatment is shifting to enhancing activities like walking and self-care. Enabling the child with cerebral palsy is the ultimate goal of therapy.

Conditions
Cerebral Palsy
Being tested
Group A, Grojup B
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group ADiagnostic test

    each participant of this groups will receive 4 weeks of FWT and 4 weeks of BWT (the training order of A group will FWT and BWT), with a washout period of 2 weeks during the post-intervention phase of the 1st period and the pre-intervention phase for the 2nd period.

  • Grojup BCombination product

    each participant of B group will receive 4 weeks of BWT and 4 weeks of FWT (the training order of group B will be BWT and FWT, opposite to group A), with a washout period of 2 weeks during the post-intervention phase of the 1st period and the pre-intervention phase for the 2nd period.

Study groups in NCT06667388
Study groupRoleWhat they receive
Group AExperimentalNot described
Receives: Diagnostic Test: Group A
Group BActive comparatorNot described
Receives: Combination Product: Grojup B

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pediatric Functional Independent Measure for Children (WeeFIM)

    The Independence Measure for Children (WeeFIM®) is frequently used as a multiple tool in pediatric clinics to assess the self-care, mobility, and psychological well-being of many groups of children, including those with developmental or developmental disabilities.

    The Functional Independence Measure for Children (WeeFIM) is an 18-item, seven-level ordinal scale instrument used to assess a child's typical and consistent performance.Children 0 to <3 years no WeeFIM (or FIM) is required. Children 3 to <12

    Measured: 12 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2024
  2. Study start1 Nov 2023
  3. Primary completion1 Jun 2024
  4. Study completion15 Nov 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06667388
Sponsor's protocol ID
MSRSW/Batch-Fall22/746
Status last verified
Oct 2024
First submitted
30 Oct 2024
Last updated
31 Oct 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group A and Grojup B in people with Cerebral Palsy, run by Superior University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 31 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pediatric Functional Independent Measure for Children (WeeFIM) (time frame: 12 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06667388 | AzTrials